Desmoid tumors and current status of management

Harish S. Hosalkar, Edward Fox, Thomas Delaney, Jesse T. Torbert, Christian M. Ogilvie, Richard D. Lackman

Research output: Contribution to journalReview article

41 Citations (Scopus)

Abstract

Desmoids are a challenging group of lesions with variable biologic behavior and local morbidity but with no metastatic potential. Modern treatment involves a multidisciplinary and individualized approach based on the location, extent, and status of recurrence. Surgery continues to be a popular therapy for small resectable tumors. Radiation is also an effective alternative; however, its potential carcinogenic side effects must be weighed carefully in the context of young patients. Low-dose chemotherapy with methotrexate and vinblastine remains a noninvasive and safe treatment with a 10-year relapse-free rate of 70%. It is clear that desmoid tumors represent an extremely mixed population of tumors with very benign to very aggressive behavior. With better understanding of the molecular and genetic basis of this disease, it is hoped that more targeted therapies with minimal toxicity profiles will become available and become the preferred therapy.

Original languageEnglish (US)
Pages (from-to)53-63
Number of pages11
JournalOrthopedic Clinics of North America
Volume37
Issue number1
DOIs
StatePublished - Jan 1 2006

Fingerprint

Aggressive Fibromatosis
Neoplasms
Therapeutics
Recurrence
Inborn Genetic Diseases
Vinblastine
Methotrexate
Molecular Biology
Radiation
Morbidity
Drug Therapy
Population

All Science Journal Classification (ASJC) codes

  • Orthopedics and Sports Medicine

Cite this

Hosalkar, H. S., Fox, E., Delaney, T., Torbert, J. T., Ogilvie, C. M., & Lackman, R. D. (2006). Desmoid tumors and current status of management. Orthopedic Clinics of North America, 37(1), 53-63. https://doi.org/10.1016/j.ocl.2005.08.004
Hosalkar, Harish S. ; Fox, Edward ; Delaney, Thomas ; Torbert, Jesse T. ; Ogilvie, Christian M. ; Lackman, Richard D. / Desmoid tumors and current status of management. In: Orthopedic Clinics of North America. 2006 ; Vol. 37, No. 1. pp. 53-63.
@article{f4e2a4b4bb594ff382bdcae4964950ed,
title = "Desmoid tumors and current status of management",
abstract = "Desmoids are a challenging group of lesions with variable biologic behavior and local morbidity but with no metastatic potential. Modern treatment involves a multidisciplinary and individualized approach based on the location, extent, and status of recurrence. Surgery continues to be a popular therapy for small resectable tumors. Radiation is also an effective alternative; however, its potential carcinogenic side effects must be weighed carefully in the context of young patients. Low-dose chemotherapy with methotrexate and vinblastine remains a noninvasive and safe treatment with a 10-year relapse-free rate of 70{\%}. It is clear that desmoid tumors represent an extremely mixed population of tumors with very benign to very aggressive behavior. With better understanding of the molecular and genetic basis of this disease, it is hoped that more targeted therapies with minimal toxicity profiles will become available and become the preferred therapy.",
author = "Hosalkar, {Harish S.} and Edward Fox and Thomas Delaney and Torbert, {Jesse T.} and Ogilvie, {Christian M.} and Lackman, {Richard D.}",
year = "2006",
month = "1",
day = "1",
doi = "10.1016/j.ocl.2005.08.004",
language = "English (US)",
volume = "37",
pages = "53--63",
journal = "Orthopedic Clinics of North America",
issn = "0030-5898",
publisher = "W.B. Saunders Ltd",
number = "1",

}

Hosalkar, HS, Fox, E, Delaney, T, Torbert, JT, Ogilvie, CM & Lackman, RD 2006, 'Desmoid tumors and current status of management', Orthopedic Clinics of North America, vol. 37, no. 1, pp. 53-63. https://doi.org/10.1016/j.ocl.2005.08.004

Desmoid tumors and current status of management. / Hosalkar, Harish S.; Fox, Edward; Delaney, Thomas; Torbert, Jesse T.; Ogilvie, Christian M.; Lackman, Richard D.

In: Orthopedic Clinics of North America, Vol. 37, No. 1, 01.01.2006, p. 53-63.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Desmoid tumors and current status of management

AU - Hosalkar, Harish S.

AU - Fox, Edward

AU - Delaney, Thomas

AU - Torbert, Jesse T.

AU - Ogilvie, Christian M.

AU - Lackman, Richard D.

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Desmoids are a challenging group of lesions with variable biologic behavior and local morbidity but with no metastatic potential. Modern treatment involves a multidisciplinary and individualized approach based on the location, extent, and status of recurrence. Surgery continues to be a popular therapy for small resectable tumors. Radiation is also an effective alternative; however, its potential carcinogenic side effects must be weighed carefully in the context of young patients. Low-dose chemotherapy with methotrexate and vinblastine remains a noninvasive and safe treatment with a 10-year relapse-free rate of 70%. It is clear that desmoid tumors represent an extremely mixed population of tumors with very benign to very aggressive behavior. With better understanding of the molecular and genetic basis of this disease, it is hoped that more targeted therapies with minimal toxicity profiles will become available and become the preferred therapy.

AB - Desmoids are a challenging group of lesions with variable biologic behavior and local morbidity but with no metastatic potential. Modern treatment involves a multidisciplinary and individualized approach based on the location, extent, and status of recurrence. Surgery continues to be a popular therapy for small resectable tumors. Radiation is also an effective alternative; however, its potential carcinogenic side effects must be weighed carefully in the context of young patients. Low-dose chemotherapy with methotrexate and vinblastine remains a noninvasive and safe treatment with a 10-year relapse-free rate of 70%. It is clear that desmoid tumors represent an extremely mixed population of tumors with very benign to very aggressive behavior. With better understanding of the molecular and genetic basis of this disease, it is hoped that more targeted therapies with minimal toxicity profiles will become available and become the preferred therapy.

UR - http://www.scopus.com/inward/record.url?scp=28344444164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28344444164&partnerID=8YFLogxK

U2 - 10.1016/j.ocl.2005.08.004

DO - 10.1016/j.ocl.2005.08.004

M3 - Review article

C2 - 16311111

AN - SCOPUS:28344444164

VL - 37

SP - 53

EP - 63

JO - Orthopedic Clinics of North America

JF - Orthopedic Clinics of North America

SN - 0030-5898

IS - 1

ER -

Hosalkar HS, Fox E, Delaney T, Torbert JT, Ogilvie CM, Lackman RD. Desmoid tumors and current status of management. Orthopedic Clinics of North America. 2006 Jan 1;37(1):53-63. https://doi.org/10.1016/j.ocl.2005.08.004